BIO Submits Comments on Medicare CY 2020 Part D Draft Call Letter
BIO submitted comments on the Centers for Medicare and Medicaid Service’s Advance Notice of Methodological Changes for Calendar Year (CY) 2020 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2020 Draft Call Letter.
BIO supports CMS’s commitment to improving the quality and delivery of care in the MA and Part D programs. It’s critically important to ensure these programs advance patient access to timely and appropriate treatment, particularly for prescription drugs and vaccines. BIO provided comments on how to update and clarify the policies and provide greater access to patients while mitigating OOP costs.